Case
The first case was a 36-year-old woman (G4P2) with six months of dysmenorrhea and menstrual high fever up to 39.5°C. She visited our hospital in Oct. 2022. The gynecological examination found a purulent cervical discharge and a 2 cm fresh granuloma at the posterior apex ( Figure 1A and B ). Contrast-enhanced ultrasound (CEUS) and magnetic resonance imaging (MRI) revealed a benign inflammatory pelvic mass measuring 6 cm in the greatest diameter, along with a posterior granuloma ( Figure 1C ). Her CA-125 level was 480IU/mL, and she had no significant medical history. The preoperative diagnosis was cervical cancer with pelvic dissemination. Figure 1 Cervical posterior isthmus penetrating pyogenic PEM. ( A and B ) Gross appearance of cervix purulent secretion and a fresh granuloma in the posterior apex, ( C ) MRI imaging showing the pelvic mass and a posterior granuloma, and ( D ) microphotograph showing endometrial glands, stroma and abscess.
Cervical posterior isthmus penetrating pyogenic PEM. ( A and B ) Gross appearance of cervix purulent secretion and a fresh granuloma in the posterior apex, ( C ) MRI imaging showing the pelvic mass and a posterior granuloma, and ( D ) microphotograph showing endometrial glands, stroma and abscess.
A diagnostic cervical mass excision was first performed, and the diagnosis of PEM with multiple abscess was made by histopathology. Treatment with ZOLADEX was recommended, but symptoms persisted, and the cervical polypoid masses reappeared, while the pelvic mass did not decrease during the third injection. Thus, a hysterectomy was conducted in Jan. 2023, and the diagnosis of cervical penetrating pyogenic PEM was confirmed by histopathology ( Figure 1D ). Her CA-125 level normalized quickly after the operation, and no recurrence happened so far.
The second case was a 36-year-old female (G1P1) and presented with four months of menstrual bleeding prolonging to 10–15 days. She was diagnosed with submucous myoma in Dec. 2018 and underwent the transcervical resection of myoma in our hospital. A 4 cm hydatidiform mass was resect and immunohistochemical (IHC) staining showed positive smooth muscle actin (SMA) and negativity for HMB-45 and Ki-67. A diagnosis of angioleiomyoma with proliferative endometrium was offered. After operation, her menstrual pattern returned normally for one year.
In Dec.2019, her menstrual period prolonged again to 20 days and ultrasound test detected a 1.5 cm myoma in last site. The myoma grew rapidly to 6cm within nine months, causing menstrual bleeding increased significantly. She referred to our hospital for second surgery in Sep.2020. Preoperative ultrasound test showed leiomyomas exhibiting rich vascularity ( Figure 2A ) and MRI image showed its signal intensity similar to that of the endometrium ( Figure 2B ). A laparoscopic removal of the mass revealed a 6 cm brittle mass with no clear myomatoid structure. IHC results showed positivity for Desmin, SMA, ER and CD10 in stromal cells, while the Ki-67 labeling index was 20%. These confirmed the diagnosis of PEM and angioleiomyoma ( Figure 2C and D ). Figure 2 PEM coexisting with angioleiomyomas. ( A ) Ultrasound image showing leiomyomas exhibiting rich vascularity, ( B ) MRI image showing its signal intensity similar to that of the endometrium, ( C and D ) microphotograph showing ectopic endometrial and angioleiomyomas.
PEM coexisting with angioleiomyomas. ( A ) Ultrasound image showing leiomyomas exhibiting rich vascularity, ( B ) MRI image showing its signal intensity similar to that of the endometrium, ( C and D ) microphotograph showing ectopic endometrial and angioleiomyomas.
The third case was a 40-year-old woman (G3P2), and she had underwent abdominal bilateral ovarian cystectomy and myomectomy in 2000. The ovarian cyst recurred with no symptoms in 2012. Until Nov. 2013, she referred to our outpatient clinic for eight months of lower abdominal pain. Ultrasound examination identified a 6 cm hypoechoic mass in posterior uterus with chaotic internal echoes, along with a 8 cm mass behind the uterus which separated unclearly from uterine wall. Further MRI test revealed left ovarian and pelvic multiple solid-cystic masses, while solid components were moderately hyperintense on FS-T2WI and markedly hyperintense on DWI ( Figure 3A and B ). Figure 3 PEM with endometrial stromal nodules and disseminated growth. ( A ) FS-T2WI shows multiple left ovarian and pelvic solid cystic masses, while solid components are moderately hyperintense; ( B ) solid components are markedly hyperintense on DWI (high b-value), ( C ) ectopic endometrial and stromal nodules, and ( D ) endometriosis and abundant stroma.
PEM with endometrial stromal nodules and disseminated growth. ( A ) FS-T2WI shows multiple left ovarian and pelvic solid cystic masses, while solid components are moderately hyperintense; ( B ) solid components are markedly hyperintense on DWI (high b-value), ( C ) ectopic endometrial and stromal nodules, and ( D ) endometriosis and abundant stroma.
During laparoscopy, a solid cystic mass in the left ovary led to a provisional diagnosis of PEM, and abdominal bilateral ovarian and total hysterectomy were eventually done due to dense adhesion. Multiple EM lesions were discovered on the uterus, sigmoid colon, rectum and left ureter extending to the kidney. The histopathological analysis revealed the widespread dissemination of endometrial stromal nodules in both ovaries, right fallopian tube, ovarian blood vessels, intestine and intestinal mesentery. IHC study of these samples revealed positive SMA, CD10, ER and PR, and the Ki-67 labeling index was 30%, supporting the clinical diagnosis of low-grade malignant potential stromal sarcoma ( Figure 3C and D ).
Intro
Endometriosis (EMs) is defined as the ectopic growth of endometrial glands and stroma outside the uterus, while polypoid endometriosis (PEM) is a rare type of EMs, which is characterized by its histological resemblance to endometrial polyps. 1 , 2 It has been revealed mostly by case reports for rare presentations. Unlike classic EMs, it occurs more in peri- or postmenopausal women and involves multiple sites, including the ovary, colon, uterine serosa, and vaginal mucosa. 3 So far, fewer than 16 cases under 40 years old and five cases with cervix affected have been reported. 3
PEM usually presents as a cystic mass with solid components or mural nodules. These solid nodules shall be differentiated with malignant cancers, endometrial stromal tumors, angioleiomyoma, fibroma and so on. Though each one of these entities has their typical histologic characteristics, immunohistochemical (IHC) staining deserves to establish the correct diagnosis. 4 In fact, endometriosis-associated stromal sarcoma is uncommon. 5 Herein, we carried out a retrospective case analysis to present three separate cases of PEM coincided with particularly rare histopathology and investigate their clinical and imaging features as well.
Conclusion
In summary, we present three separate and unique cases of PEM with multiple cervical abscesses, uterine angioleiomyomas, and widely disseminated stromal nodules, respectively. Although PEM, endometrial stromal nodules and angioleiomyomas are rare and morphologic mimickers, immunohistochemical staining can play a role in their differential diagnosis.
Discussion
This paper, to the best of our knowledge, is the first case series reported in the literature of PEM coexisting with cervical multiple abscesses, uterine angioleiomyomas, or multi-organ disseminated endometrial stromal nodules, respectively.
EM patients, even virginal young women, are at higher risk for developing ovarian abscess and tends to be more severe, frequently requiring surgical intervention. 6 , 7 The main symptoms are acute fever and abdominal pain, which might not be related to menstrual cycle. To date, there are no reports of PEM presented with abscesses, and cases with cervix involved are documented only in five patients. 3 The case 1 was cervical PEM with multiple abscess and exhibited cyclic high fever during menstruation. As imaging features, the black rim sign on MRI and CEUS showing a global hyper-enhancement pattern with fast forward and reverse compared to normal myometrium suggested the diagnosis of PEM with abscess. 8–10 Due to multiple abscess, she did not respond to treatment with ZOLADEX, and a radical hysterectomy should be deserved.
There has been one report about intestinal PEM with abundant leiomyoma-like smooth muscle components, but PEM with uterine angioleiomyoma has not been documented before. 11 Angioleiomyomas in female urogenital tract is rare, accounting for 0.4% of uterine leiomyomas, and the intracavitary lesions are extremely unusual. 4 , 12 Case 2 is the second report of intracavitary angioleiomyomas and is also the first report of angioleiomyomas coexisted with PEM. It is important to distinguish this condition from atypical polypoid adenomyomas through IHC. PEM with angioleiomyomas showed diffuse and strong positivity for SMA, desmin and CD10 in stromal cells, while CD10 expression in atypical polypoid adenomyomas was negative. 4 , 13
Ovarian PEM often appears as papillary masses in endometriotic cysts, but cysts with solid components or nodules may indicate malignancy. Benign nodules will not be enhanced, while malignant nodules are enhanced by MRI test as shown in case 3. 5 Endometrial stromal sarcoma from endometriotic lesions is rare but can spread aggressively in the abdomen. 14 The widespread distribution of endometrial stromal nodules in multiple organs along with the IHC results provides evidence for the diagnosis of low-grade malignant potential stromal sarcoma in case 3. The patient’s survival during an almost 11-year follow-up period further validates the favorable influence of endometriosis on the patient’s prognosis. 15
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.